Vectors Research Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.12M | Hold |
4,267
| – | – | 1.34% | 22 |
|
|
2026
Q1 | $3.92M | Buy |
4,267
+7
| +0.2% | +$7.1K | 1.15% | 26 |
|
|
2025
Q4 | $4.58M | Buy |
4,260
+1
| +0% | +$956 | 1.4% | 19 |
|
|
2025
Q3 | $3.25M | Hold |
4,259
| – | – | 1.02% | 28 |
|
|
2025
Q2 | $3.32M | Hold |
4,259
| – | – | 1.14% | 24 |
|
|
2025
Q1 | $3.52M | Sell |
4,259
-65
| -2% | -$54.1K | 1.23% | 22 |
|
|
2024
Q4 | $3.34M | Hold |
4,324
| – | – | 1.14% | 26 |
|
|
2024
Q3 | $3.84M | Hold |
4,324
| – | – | 1.16% | 23 |
|
|
2024
Q2 | $3.92M | Sell |
4,324
-9
| -0.2% | -$7.2K | 1.2% | 22 |
|
|
2024
Q1 | $3.37M | Sell |
4,333
-135,617
| -97% | -$96.5M | 0.95% | 27 |
|
|
2023
Q4 | $2.47M | Buy |
139,950
+135,535
| +3,070% | +$79.1M | 0.7% | 39 |
|
|
2023
Q3 | $2.37M | Sell |
4,415
-25
| -0.6% | -$12.9K | 0.77% | 32 |
|
|
2023
Q2 | $2.08M | Sell |
4,440
-26
| -0.6% | -$10.9K | 0.59% | 47 |
|
|
2023
Q1 | $1.53M | Sell |
4,466
-200
| -4% | -$67.5K | 0.4% | 62 |
|
|
2022
Q4 | $1.71M | Hold |
4,666
| – | – | 0.44% | 59 |
|
|
2022
Q3 | $1.51M | Hold |
4,666
| – | – | 0.43% | 59 |
|
|
2022
Q2 | $1.51M | Hold |
4,666
| – | – | 0.38% | 65 |
|
|
2022
Q1 | $1.34M | Hold |
4,666
| – | – | 0.29% | 77 |
|
|
2021
Q4 | $1.29M | Buy |
4,666
+36
| +0.8% | +$9.13K | 0.27% | 76 |
|
|
2021
Q3 | $1.07M | Hold |
4,630
| – | – | 0.25% | 82 |
|
|
2021
Q2 | $1.06M | Hold |
4,630
| – | – | 0.27% | 83 |
|
|
2021
Q1 | $865K | Hold |
4,630
| – | – | 0.24% | 85 |
|
|
2020
Q4 | $782K | Buy |
4,630
+550
| +13% | +$82.1K | 0.24% | 81 |
|
|
2020
Q3 | $604K | Buy |
4,080
+100
| +3% | +$15.5K | 0.22% | 82 |
|
|
2020
Q2 | $653K | Hold |
3,980
| – | – | 0.26% | 74 |
|
|
2020
Q1 | $552K | Hold |
3,980
| – | – | 0.26% | 66 |
|
|
2019
Q4 | $523K | Hold |
3,980
| – | – | 0.21% | 74 |
|
|
2019
Q3 | $445K | Hold |
3,980
| – | – | 0.22% | 76 |
|
|
2019
Q2 | $441K | Hold |
3,980
| – | – | 0.24% | 73 |
|
|
2019
Q1 | $516K | Buy |
+3,980
| New | +$484K | 0.29% | 67 |
|
|
2018
Q4 | – | Sell |
-3,980
| Closed | -$342K | – | 700 |
|
|
2018
Q3 | $342K | Buy |
+3,980
| New | +$398K | 0.21% | 80 |
|
Other funds holding LLY
Vectors Research Management's LLY Position: Q2 2026 in Review
Vectors Research Management held its Eli Lilly (LLY) position steady in Q2 2026 at 4,267 shares worth $5.12M. The position accounts for 1.34% of the portfolio, ranked #22.
Vectors Research Management first reported a position in LLY in Q3 2018 and has held it in 31 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vectors Research Management held 4,267 shares of Eli Lilly worth $5.12M as of Q2 2026.
- Vectors Research Management left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 1.34% of Vectors Research Management's portfolio in Q2 2026, its #22 holding.
- Vectors Research Management first reported a position in Eli Lilly in Q3 2018 and has held it in 31 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.